Microbiome News
Therapeutics
FDA-Approved Fecal Microbiota Therapies for C. difficile
A new review highlights FDA-approved fecal microbiota therapies that reduce recurrence of C. difficile infection. The review explores clinic…
Section
Therapeutics
FDA approvals, live biotherapeutics and the clinical pipeline turning microbes into medicine.
Therapeutics
A stool transplant made cancer immunotherapy work better — across two cancers
In the phase 2 FMT-LUMINate trial, pairing a healthy-donor fecal transplant with checkpoint inhibitors pushed response rates to 80% in lung …
Therapeutics
It’s official: the FDA now approves medicines made of microbes
Within five months the agency cleared two first-in-class fecal-microbiota products for recurrent C. difficile — Ferring’s Rebyota and, in a …
The microbiome, once a week.
The research that mattered, the hype that didn’t, and one idea worth carrying around. No spam, unsubscribe anytime.